Table 3.
Prognostic impact of study outcomes on PEmb‐QoL dimensions
| Study outcomes | Dyspnea (NYHA class III/IV) (19/101 [18.8%]) | RV dysfunction on TTE (25/91 [27.5%]) | Post‐PE impairment (23/91 [25.2%]) | Depression (14/89 [15.7%]) | Cancer (17/100 [17.0%]) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Frequency of complaints (FO) | 5.2 (2.0‐13.3) | .001 | 1.3 (0.6‐2.6) | .500 | 1.5 (0.7‐3.0) | .283 | 1.1 (0.5‐2.5) | .820 | 1.0 (0.4‐2.2) | .933 |
| Activities of daily living limitations (AD) | 10.6 (3.0‐36.9) | <.001 | 1.1 (0.5‐2.7) | .793 | 1.4 (0.6‐3.6) | .423 | 2.6 (0.7‐9.2) | .134 | 2.1 (0.8‐5.6) | .150 |
| Work‐related problems (WR) | 49.0 (7.2‐332.5) | <.001 | 2.5 (0.8‐7.7) | .109 | 3.4 (1.1‐10.8) | .041 | 1.7 (0. 4‐7.1) | .501 | 1.3 (0.4‐4.6) | .670 |
| Social limitations (SL) | 3.7 (2.1‐6.6) | <.001 | 1.1 (0.7‐1.7) | .660 | 1.2 (0.8‐1.8) | .416 | 1.0 (0.6‐1.7) | .979 | 1.0 (0. 6‐1.6) | .910 |
| Intensity of complaints (IO) | 4.5 (2.3‐9.0) | <.001 | 1.2 (0.8‐1.8) | .451 | 1.3 (0.8‐1.9) | .244 | 1.5 (0.9‐2.4) | .112 | 1.0 (0.7‐1.7) | .875 |
| Emotional complaints (EC) | 1.4 (0.8‐2.7) | .242 | 0.9 (0.5‐1.5) | .678 | 1.0 (0.5‐1.7) | .862 | 1.3 (0.7‐2.4) | .467 | 1.1 (0.6‐2.1) | .671 |
Abbreviations: CI, confidence interval; NYHA, New York Heart Association; OR, odds ratio; PE, pulmonary embolism; PEmb‐QoL, pulmonary embolism‐quality of life; RV, right ventricular; TTE, transthoracic echocardiography.